Alexis Ann LeVee MD; 2025 SABCS: Pre-Operative Gut Microbiome Predicts Complete Response to Immune Checkpoint Inhibition in Patients with Early-stage...
An interview with: Christof Vulsteke MD PhD, Medical Oncologist, Head of the Integrated Cancer Center Ghent, Belgium BERLIN, Germany—Patients with...
An interview with: Domenica Lorusso MD PhD, Director of the Gynaecological Oncology Unit, full Professor of Obstetrics and Gynaecology, Humanitas...
Reporter: Sarah Maxwell BARCELONA—Pembrolizumab did not significantly improve overall survival (OS) or progression free survival (PFS) compared with...
Audio Journal of Oncology Podcast Pembrolizuab Monotherapy Extended Survival in Advanced Lung Cancer Play Episode Pause Episode Mute/Unmute Episode...
Audio Journal of Oncology Podcast First-Line Pembrolizumab Boosts Survival in PD-L1-Positive Advanced Lung Cancer Play Episode Pause Episode...
Audio Journal of Oncology Podcast Lung Cancer—First-Line Checkpoint Inhibitor Combination Benefit Play Episode Pause Episode Mute/Unmute...








